Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19
The ongoing COVID-19 pandemic still requires fast and effective efforts from all fronts, including epidemiology, clinical practice, molecular medicine, and pharmacology. A comprehensive molecular framework of the disease is needed to better understand its pathological mechanisms, and to design succe...
Main Authors: | Paola Stolfi, Luigi Manni, Marzia Soligo, Davide Vergni, Paolo Tieri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.545089/full |
Similar Items
-
Network bioinformatics analysis provides insight into drug repurposing for COVID-19
by: Xu Li, et al.
Published: (2021-06-01) -
Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
by: Dan-Yang Liu, et al.
Published: (2021-04-01) -
Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing
by: Guillermo de Anda-Jáuregui, et al.
Published: (2018-03-01) -
SAveRUNNER: an R-based tool for drug repurposing
by: Giulia Fiscon, et al.
Published: (2021-03-01) -
Drug Repurposing Using Biological Networks
by: Francisco Javier Somolinos, et al.
Published: (2021-06-01)